International Conference on Cancer Research and Anticancer Therapies

Important dates

1. 20 Nov

   Abstract / full paper deadline

   In 5 days

2. 17 Dec

   Conference

   springfield, Missouri, USA

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

The key intention of ICCRAT is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world. In addition this gathering will help the delegates to establish research or business relations as well as to find international linkage for future collaborations in their career path. We hope that ICCRAT outcome will lead to significant contributions to the knowledge base in these up-to-date scientific fields in scope.

Topics and scope

• Anticancer drug development
• Pharmacokinetic, pharmacodynamic, and pharmacogenetic principles
• Cancer chemotherapy
• Genotoxic therapy
• Novel targets in the cell cycle and cell cycle checkpoints
• Molecular regulation of cell cycle progression and checkpoints
• Agents and strategies for therapeutic interference
• Growth factor and signal transduction targets for cancer therapy
• Nuclear hormone receptors as targets for cancer therapy
• Implications for drug discovery and development
• Cell death pathways as targets for anticancer drugs
• Drug resistance pathways as targets
• Cancer invasion and metastasis
• Cell adhesion in cancer
• Cancer cell motility
• Inflammatory response to cancer
• Proteolytic enzymes implicated in cancer invasion
• Gene-directed enzyme prodrug therapy
• Tumor antigens as targets for anticancer drug development
• Structure-based drug design and its contributions to cancer chemotherapy
• The contribution of synthetic organic chemistry to anticancer drug development
• Development of synthetic compounds: structure–activity relationships
• Immunotoxins: synthetic organic chemistry applied to large molecules
• Organic synthesis in rational design
• Biosynthetic products for anticancer drug design and treatment
• DNA-encoded peptide libraries and drug discovery
• High throughput screening for novel anticancer drug discovery
• Importance of mechanism-based targets in postgenomic drug discovery
• Tumor cell cultures in drug development

Call for papers

Abstracts are due by 20 November 2026. Submission details are on the official website.